Literature DB >> 8592656

Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo.

E Nakashima1, N Mukaida, Y Kubota, K Kuno, K Yasumoto, F Ichimura, I Nakanishi, M Miyasaka, K Matsushima.   

Abstract

PURPOSE: To evaluate the effect of monocyte chemotactic and activating factor (MCAF/MCP-1/JE) on tumor progression and metastasis.
METHODS: Cachexia-inducing adenocarcinoma cells (cell line colon 26, clone 20) were transfected with either a control plasmid or MCAF expression vector. Spontaneous lung metastases were determined in mouse.
RESULTS: The production of MCAF reached 0.4 ng/ml in vitro when transfectant cells were cultured at a cell density of 5 x 10(4) cells/ml for 3 days. Transfection of MCAF expression vector did not affect the growth rate in vitro. Also, after MCAF-transfection, the size of tumors after intra-footpad inoculation was similar to that of the parental cells. When the primary tumors were resected on the 10th day after inoculation, the incidence of spontaneous lung metastasis was less than 20% in both cells. The number of endothelial cells in the primary tumor rapidly increased from the 10th to the 14th day after inoculation, as revealed by immunohistochemical staining. In accordance with enhanced angiogenesis, the incidence rates of spontaneous metastasis increased when the primary tumors were resected on the 14th day after inoculation. Moreover, the spontaneous lung metastases were augmented in the animals injected with MCAF-transfectants compared to those injected with parental cells with a concomitant increase of angiogenesis.
CONCLUSIONS: These results suggest that MCAF may augment the metastastic potential by modulating tumor associated angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592656     DOI: 10.1023/A:1016276613684

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  A sensitive enzyme-linked immunosorbent assay for human interleukin-8.

Authors:  Y Ko; N Mukaida; A Panyutich; N N Voitenok; K Matsushima; T Kawai; T Kasahara
Journal:  J Immunol Methods       Date:  1992-05-18       Impact factor: 2.303

2.  A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

Authors:  P Gunning; J Leavitt; G Muscat; S Y Ng; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

Review 3.  Review of the chemokine meeting the Third International Symposium of Chemotactic Cytokines.

Authors:  D D Taub; J J Oppenheim
Journal:  Cytokine       Date:  1993-05       Impact factor: 3.861

4.  Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor.

Authors:  Y Nakano; T Kasahara; N Mukaida; Y C Ko; M Nakano; K Matsushima
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF).

Authors:  Y Furutani; H Nomura; M Notake; Y Oyamada; T Fukui; M Yamada; C G Larsen; J J Oppenheim; K Matsushima
Journal:  Biochem Biophys Res Commun       Date:  1989-02-28       Impact factor: 3.575

6.  Synergism between human recombinant monocyte chemotactic and activating factor and lipopolysaccharide for activation of antitumor properties in human blood monocytes.

Authors:  R K Singh; I J Fidler
Journal:  Lymphokine Cytokine Res       Date:  1993-10

7.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

Review 8.  JE/MCP-1: an early-response gene encodes a monocyte-specific cytokine.

Authors:  B J Rollins
Journal:  Cancer Cells       Date:  1991-12

9.  Activation of CD44 induces ICAM-1/LFA-1-independent, Ca2+, Mg(2+)-independent adhesion pathway in lymphocyte-endothelial cell interaction.

Authors:  N Toyama-Sorimachi; K Miyake; M Miyasaka
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

10.  Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.

Authors:  K Matsushima; C G Larsen; G C DuBois; J J Oppenheim
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  Interaction of Bartonella henselae with endothelial cells promotes monocyte/macrophage chemoattractant protein 1 gene expression and protein production and triggers monocyte migration.

Authors:  Amy M McCord; Andrew W O Burgess; Melissa J Whaley; Burt E Anderson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers.

Authors:  Élora Midavaine; Jérôme Côté; Philippe Sarret
Journal:  Cancer Metastasis Rev       Date:  2021-05-11       Impact factor: 9.264

4.  Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells.

Authors:  Melanie Mestdagt; Myriam Polette; Giovanna Buttice; Agnes Noël; Atsuhisa Ueda; Jean-Michel Foidart; Christine Gilles
Journal:  Int J Cancer       Date:  2006-01-01       Impact factor: 7.396

5.  A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice.

Authors:  E Nakashima; A Oya; Y Kubota; N Kanada; R Matsushita; K Takeda; F Ichimura; K Kuno; N Mukaida; K Hirose; I Nakanishi; T Ujiie; K Matsushima
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

Review 6.  Nf-kappa B, chemokine gene transcription and tumour growth.

Authors:  Ann Richmond
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

7.  Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model.

Authors:  Munehisa Takahashi; Hiroshi Miyazaki; Mutsuo Furihata; Hirofumi Sakai; Takeo Konakahara; Morihiro Watanabe; Tomoko Okada
Journal:  Clin Exp Metastasis       Date:  2009-07-24       Impact factor: 5.150

8.  Synergistic antitumor interaction of human monocyte chemotactant protein-1 gene transfer and modulator for tumor-infiltrating macrophages.

Authors:  E Nakashima; Y Kubota; R Matsushita; E Ozaki; F Ichimura; S Kawahara; I Nakanishi; K Kuno; K Matsushima
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

Review 9.  Immunotherapeutic approaches for glioma.

Authors:  Hideho Okada; Gary Kohanbash; Xinmei Zhu; Edward R Kastenhuber; Aki Hoji; Ryo Ueda; Mitsugu Fujita
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

10.  The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment.

Authors:  Ronit Vogt Sionov; Zvi G Fridlender; Zvi Granot
Journal:  Cancer Microenviron       Date:  2014-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.